Abstract
We thought an appropriate way to celebrate the seminal contribution of Kier is to explore his influence on science, looking for the impact of his research through the citation of his scientific production. From a bibliometric approach the impact of Kier’s work is addressed as an individual within a community. Reviewing data from his curriculum vitae, as well as from the ISI Web of Knowledge (ISI), his role within the scientific community is established and the way his scientific results circulate is studied. His curriculum vitae is explored emphasising the approaches he used in his research activities and the social ties with other actors of the community. The circulation of Kier’s publications in the ISI is studied as a means for spreading and installing his discourse within the community. The citation patterns found not only show the usage of Kier’s scientific results, but also open the possibility to identify some characteristics of this discursive community, such as a common vocabulary and common research goals. The results show an interdisciplinary research work that consolidates a scientific community on the topic of drug discovery.
Keywords: Bibliometrics, discourse community, drug design, Lemont B. Kier, topological descriptors, scientific community.
Current Computer-Aided Drug Design
Title:Lemont B. Kier: A Bibliometric Exploration of his Scientific Production and its Use
Volume: 9 Issue: 4
Author(s): Guillermo Restrepo, Eugenio J. Llanos and Adriana E. Silva
Affiliation:
Keywords: Bibliometrics, discourse community, drug design, Lemont B. Kier, topological descriptors, scientific community.
Abstract: We thought an appropriate way to celebrate the seminal contribution of Kier is to explore his influence on science, looking for the impact of his research through the citation of his scientific production. From a bibliometric approach the impact of Kier’s work is addressed as an individual within a community. Reviewing data from his curriculum vitae, as well as from the ISI Web of Knowledge (ISI), his role within the scientific community is established and the way his scientific results circulate is studied. His curriculum vitae is explored emphasising the approaches he used in his research activities and the social ties with other actors of the community. The circulation of Kier’s publications in the ISI is studied as a means for spreading and installing his discourse within the community. The citation patterns found not only show the usage of Kier’s scientific results, but also open the possibility to identify some characteristics of this discursive community, such as a common vocabulary and common research goals. The results show an interdisciplinary research work that consolidates a scientific community on the topic of drug discovery.
Export Options
About this article
Cite this article as:
Restrepo Guillermo, Llanos J. Eugenio and Silva E. Adriana, Lemont B. Kier: A Bibliometric Exploration of his Scientific Production and its Use, Current Computer-Aided Drug Design 2013; 9 (4) . https://dx.doi.org/10.2174/15734099113096660043
DOI https://dx.doi.org/10.2174/15734099113096660043 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Context-Dependency of Relations Between Cardiovascular Phenotypes and Genes Involved in Sodium Homeostasis: Findings from the European Project on Genes in Hypertension
Current Hypertension Reviews Update on the Cardiac Safety of Moxifloxacin
Current Drug Safety Neprilysin: A Potential Therapeutic Target of Arterial Hypertension?
Current Cardiology Reviews The Role of Molecular Imaging in the Assessment of Cardiac Amyloidosis: State-of-the-Art
Current Radiopharmaceuticals Cross-Reactivity in Cell-Mediated and IgE-Mediated Hypersensitivity to Glucocorticoids
Current Pharmaceutical Design Investigational Positive Inotropic Agents for Acute Heart Failure
Cardiovascular & Hematological Disorders-Drug Targets Computational Studies of Competitive Inhibitors of Nitric Oxide Synthase (NOS) Enzymes: Towards the Development of Powerful and Isoform-Selective Inhibitors
Current Medicinal Chemistry Biomarkers of Acute Kidney Injury in Critical Care Medicine: A Literature Review Based on Recent Patent Applications
Recent Patents on Biomarkers The Treatment of Behavioral and Psychological Symptoms of Dementia: Weighing Benefits and Risks
Current Alzheimer Research Clinical Implications of Non-Invasive Measurement of Central Aortic Blood Pressure
Current Vascular Pharmacology Defining Pharmacokinetics for Individual Patient Dosimetry in Routine Radiopeptide and Radioimmunotherapy of Cancer: Australian Experience
Current Pharmaceutical Design Relationship Between the Pharmacokinetics of Levosimendan and Its Effects on Cardiovascular System
Current Drug Metabolism Aortic Dissection: A Review of the Pathophysiology, Management and Prospective Advances
Current Cardiology Reviews Induction of Cytochrome P450 3A by the Ginkgo biloba Extract and Bilobalides in Human and Rat Primary Hepatocytes
Drug Metabolism Letters Inhibition of Brain Ischemia-Caused Notch Activation in Microglia May Contribute to Isoflurane Postconditioning-Induced Neuroprotection in Male Rats
CNS & Neurological Disorders - Drug Targets Endocannabinoids and their Involvement in the Neurovascular System
Current Neurovascular Research Role of Endothelial Nitric Oxide in Cerebrovascular Regulation
Current Pharmaceutical Biotechnology Buprenorphine-Mediated Transition from Opioid Agonist to Antagonist Treatment: State of the Art and New Perspectives
Current Drug Abuse Reviews Cardiovascular Pharmacogenomics
Current Pharmacogenomics and Personalized Medicine ABC Transporters, Bile Acids, and Inflammatory Stress in Liver Cancer
Current Pharmaceutical Biotechnology